Skip to content
ASTRAL

Compound research

What is KPV in the literature?

KPV is the Lys-Pro-Val C-terminal tripeptide of alpha-MSH. Published work examines signaling and antimicrobial or inflammatory-pathway models; it does not establish human safety or intended use.

View KPVCheck batch records
Research compoundKPV
CAS number67727-97-3
Molecular formulaC16H30N4O4
Molecular weight342.44 g/mol

Source trail

Selected references

  1. Cell-culture study

    alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.

    Elliott RJ, Szabo M, Wagner MJ, et al. Journal of Investigative Dermatology (2004).

    Examines KPV-related signaling in a human keratinocyte cell model.

    PMID 15102092 · DOI 10.1111/j.0022-202X.2004.22404.x

  2. In vitro study

    Antimicrobial effects of alpha-MSH peptides.

    Cutuli M, Cristiani S, Lipton JM, et al. Journal of Leukocyte Biology (2000).

    Studies alpha-MSH-derived peptides in an experimental antimicrobial model.

    PMID 10670585 · DOI 10.1002/jlb.67.2.233

How to interpret this page

These sources establish research context only. They do not verify an Astral lot, support dosing or human use, or prove safety or efficacy. Use the lot-specific COA for analytical evidence.

Editorially curated and source-verified; not independently peer-reviewed by Astral. Last source check: 2026-07-21. Read the editorial policy.